Stockreport

HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation [Seeking Alpha]

HilleVax, Inc.  (HLVX) 
PDF Several other studies have already been initiated using HIL-214 for the prevention of Norovirus-related gastroenteritis such as NOR-109, NOR-206, and NOR-215. The glo [Read more]